These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 7940563)
21. Experimental studies on immunosuppression: how do they predict for man? Vos JG; Van Loveren H Toxicology; 1998 Aug; 129(1):13-26. PubMed ID: 9769107 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of multivariate statistical methods for analysis and modeling of immunotoxicology data. Keil D; Luebke RW; Ensley M; Gerard PD; Pruett SB Toxicol Sci; 1999 Oct; 51(2):245-58. PubMed ID: 10543026 [TBL] [Abstract][Full Text] [Related]
25. The immunopharmacology of immunotoxicology, and immunorestoration. Caspritz G; Hadden J Toxicol Pathol; 1987; 15(3):320-32. PubMed ID: 3317770 [TBL] [Abstract][Full Text] [Related]
26. Perturbations of the immune system by xenobiotics. Luster MI; Ackermann MF; Germolec DR; Rosenthal GJ Environ Health Perspect; 1989 May; 81():157-62. PubMed ID: 2667976 [TBL] [Abstract][Full Text] [Related]
27. Immunotoxicology: opportunities for non-animal test development. Corsini E; Roggen EL Altern Lab Anim; 2009 Sep; 37(4):387-97. PubMed ID: 19807211 [TBL] [Abstract][Full Text] [Related]
28. Nonhuman primates as animal models for toxicology research. Burbacher TM; Grant KS Curr Protoc Toxicol; 2001; Chapter 1():Unit1.1. PubMed ID: 23045019 [TBL] [Abstract][Full Text] [Related]
29. Approaches to the evaluation of chemical-induced immunotoxicity. Krzystyniak K; Tryphonas H; Fournier M Environ Health Perspect; 1995 Dec; 103 Suppl 9(Suppl 9):17-22. PubMed ID: 8635435 [TBL] [Abstract][Full Text] [Related]
31. The role of conventional pathology and toxicology in evaluating the immunotoxic potential of xenobiotics. Bloom JC; Thiem PA; Morgan DG Toxicol Pathol; 1987; 15(3):283-93. PubMed ID: 3317768 [TBL] [Abstract][Full Text] [Related]
32. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary. Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359 [TBL] [Abstract][Full Text] [Related]
34. Contribution of "in vitro" assays to preclinical and premarketing testing in immunotoxicology. Procházková J Cent Eur J Public Health; 1993 Dec; 1(2):101-5. PubMed ID: 8004034 [TBL] [Abstract][Full Text] [Related]
35. Histopathologic approaches to detect changes indicative of immunotoxicity. Kuper CF; Harleman JH; Richter-Reichelm HB; Vos JG Toxicol Pathol; 2000; 28(3):454-66. PubMed ID: 10862566 [TBL] [Abstract][Full Text] [Related]
36. Promotion of research on in vitro immunotoxicology. Balls M; Sabbioni E Sci Total Environ; 2001 Apr; 270(1-3):21-5. PubMed ID: 11327393 [TBL] [Abstract][Full Text] [Related]
37. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials. EFSA GMO Panel Working Group on Animal Feeding Trials Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408 [TBL] [Abstract][Full Text] [Related]
38. Immunotoxicology: an overview. Dean JH; Thurmond LM Toxicol Pathol; 1987; 15(3):265-71. PubMed ID: 3317766 [TBL] [Abstract][Full Text] [Related]
39. Feasibility of human trials to assess developmental immunotoxicity, and some comparison with data on New World monkeys. Neubert RT; Webb JR; Neubert D Hum Exp Toxicol; 2002; 21(9-10):543-67. PubMed ID: 12458914 [TBL] [Abstract][Full Text] [Related]